Includes cardiometabolic-related technologies including indications like NASH, Cirrhosis, CKD, nephrosis, and diabetic kidney disease.

Includes technologies from the cell and gene therapy space, including NK cells, stem cells, T cells, AAV, Adenovirus, CRISPR, DNA, Lentivirus, RNA and vaccinia.

Includes AI-driven-medical devices, therapeutic modalities, diagnostics and assays, life science research tools and digital health.

Includes technologies from the rare disease space, including orphan- and ultra-rare-diseases.

Includes regenerative medicine-related technologies including tissue repair, bone regeneration and wound healing.

Includes technologies from the women’s and reproductive health spaces including infertility, contraception, gynecological disorders as well as female-specific cancers like ovarian, uterine, and breast.